pneumonia
caus
novel
coronaviru
known
novel
coronaviru
diseas
appear
wuhan
china
decemb
approxim
patient
develop
acut
respiratori
distress
syndrom
ard
within
short
period
time
reduc
respiratori
symptom
improv
prognosi
respiratori
support
import
mean
life
support
noninvas
respiratori
support
system
includ
variou
convent
oxygen
therapi
noninvas
posit
pressur
ventil
nppv
highflow
nasal
cannula
hfnc
commonli
use
howev
efficaci
safeti
remain
unclear
whether
increas
risk
aerosol
dispers
diseas
transmiss
particularli
controversi
given
mani
similar
pneumonia
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
studi
primarili
discuss
clinic
indic
provid
detail
regard
prevent
nosocomi
infect
nppv
hfnc
treatment
pneumonia
base
previou
clinic
data
use
nppv
sar
mer
experi
treatment
pneumonia
clinic
efficaci
nppv
nppv
reduc
rate
tracheal
intub
therefor
theoret
significantli
reduc
risk
infect
medic
personnel
tracheal
intub
artifici
airway
manag
pneumonia
patient
recent
retrospect
epidemiolog
studi
pneumonia
patient
china
reveal
nppv
commonli
use
mechan
ventil
method
acut
respiratori
failur
rate
use
noninvas
invas
mechan
ventil
respect
howev
efficaci
ventil
method
need
investig
littl
clinic
data
nppv
sar
smallsampl
singlecent
retrospect
studi
china
nppv
failur
rate
approxim
cheung
et
al
studi
hong
kong
patient
sar
acut
respiratori
failur
oxygen
flow
lmin
percutan
oxygen
satur
spo
reveal
nppv
could
prevent
tracheal
intub
patient
significantli
reduc
time
spent
intens
care
unit
icu
report
nppv
treatment
mer
also
limit
degre
lung
extrapulmonari
injuri
patient
mer
significantli
higher
patient
without
mer
failur
rate
nppv
rel
high
addit
current
evid
clinic
guidelin
recommend
nppv
treat
acut
hypox
respiratori
failur
pandem
viral
ill
therefor
believ
nppv
current
use
firstlin
treatment
correct
respiratori
failur
patient
pneumonia
strictli
select
earlystag
patient
mildtomoder
partial
pressur
arteri
oxygen
fraction
inspir
oxygen
fio
mmhg
hypox
respiratori
failur
especi
unit
limit
number
invas
ventil
recommend
nppv
attempt
short
period
time
hour
intub
immedi
improv
observ
addit
earlystag
identif
highrisk
factor
shock
metabol
acidosi
multipl
organ
failur
pao
fio
mmhg
h
nppv
treatment
sever
hypoxemia
pao
fio
mmhg
simplifi
acut
physiolog
score
ii
sap
ii
tidal
volum
vt
mlkg
elev
paco
respiratori
rate
breathsmin
nppv
failur
treatment
hypox
respiratori
failur
improv
safeti
nppv
treatment
nppv
avoid
patient
hemodynam
instabl
multipl
organ
failur
disord
conscious
mucu
drainag
disord
nppv
aerosol
dispers
diseas
transmiss
problem
notabl
nppv
lead
aerosol
transmiss
use
vitro
simul
experi
shown
nppv
lead
dispers
exhal
aerosol
within
patient
addit
dispers
rang
increas
increas
air
leakag
increas
inspiratori
pressur
consid
nppv
import
form
aerosol
transmiss
patient
ward
howev
clinic
studi
use
nppv
sar
clearli
demonstr
nppv
increas
risk
infect
transmiss
infect
patient
medic
staff
convers
nppv
mask
may
also
reduc
aerosol
exhal
cough
talk
recent
studi
shown
nppv
lowrisk
airborn
rout
good
interfac
fit
therefor
still
unclear
whether
nppv
increas
risk
aerosol
diffus
diseas
transmiss
especi
respect
transmiss
medic
personnel
use
nppv
pneumonia
still
requir
strict
control
medic
environ
vigil
monitor
infect
risk
medic
personnel
tabl
show
specif
prevent
control
measur
prevent
aerosol
product
diseas
transmiss
patient
ward
nppv
clinic
efficaci
hfnc
hfnc
new
form
noninvas
respiratori
support
adjust
maximum
ga
flow
lmin
fio
clinic
data
exist
regard
use
hfnc
sar
mer
clinic
efficaci
hfnc
need
investig
howev
patient
noninfecti
mildtomoder
hypox
respiratori
failur
compar
convent
oxygen
therapi
hfnc
reduc
rate
tracheal
intub
mortal
therefor
hfnc
treatment
pneumonia
attempt
hypoxemia
treat
use
convent
oxygen
therapi
devic
nppv
toler
follow
situat
mildtomoder
hypoxemia
mmhg
pao
fio
mmhg
indic
emerg
tracheal
intub
rel
stabl
vital
sign
hfnc
avoid
patient
hemodynam
instabl
multipl
organ
failur
disord
conscious
therapeut
respons
close
monitor
hour
hfnc
treatment
patient
switch
noninvas
invas
posit
pressur
ventil
follow
condit
persist
respiratori
rate
breathsminut
spo
paradox
breath
andor
continu
assist
respiratori
muscl
activ
ph
partial
pressur
arteri
carbon
dioxid
paco
mmhg
nosocomi
infect
prevent
control
prevent
control
nosocomi
infect
hfnc
therapi
provid
follow
suggest
base
experi
dispos
singleus
highflow
nasal
plug
tube
use
hfnc
treatment
patient
instruct
breath
mouth
close
much
possibl
wear
surgic
mask
oxygen
mask
condens
circuit
clean
time
manner
avoid
product
aerosol
caus
high
flow
ga
condens
water
enter
nasal
caviti
stimul
cough
patient
recent
evid
show
dispers
distanc
exhal
gase
hfnc
treatment
limit
risk
airborn
transmiss
low
howev
loos
connect
hfnc
nasal
plug
significantli
increas
dispers
distanc
exhal
gase
mm
mm
therefor
attent
paid
correct
posit
wear
highflow
nasal
plug
none
